Action Required: Password Reset on Next Login
As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.
To reset your password, please visit the Reset Password page.
We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Washington University School of Medicine in St. Louis
Headquarters: St. Louis, MO, United States of America
Website: http://medicine.wustl.edu/
Year Founded: 1891
Status: Non-biopharma
Biopharma related deals can be found by searching the organization's name in the Deals Module.
BioCentury | Oct 31, 2024
Discovery & Translation
Science Spotlight: Macrophage-fibroblast cross-talk in heart failure
BioCentury’s roundup of translational innovations also includes synthetic gene regulators, three longevity genes and more
BioCentury | Feb 29, 2024
Regulation
Ultrarare inflection point: stakeholders argue for biomarker-based approvals
Reagan-Udall Foundation meeting on biomarkers could change FDA policy on neuronal MPS endpoints, unleash approvals
BioCentury | Aug 23, 2023
Discovery & Translation
Resetting the iPS cell epigenome; plus microglia-targeted AAV and more
BioCentury’s roundup of translational innovations
BioCentury | Jun 16, 2023
Discovery & Translation
Cardea’s COVID biosensor; plus gut microbes in Alzheimer’s risk and more
BioCentury’s roundup of translational news
BioCentury | Nov 14, 2022
Product Development
Roche miss could hold key lessons for amyloid targeting in Alzheimer’s
Subcutaneous mAb gantenerumab won’t be the first to circumvent CMS’s NCD after all
BioCentury | Aug 30, 2022
Product Development
Aug. 30 Quick Takes: Lumakras meets in lung cancer Phase III
Plus vopratelimab miss weighs on Jounce and updates from MedGenome, Sangamo and more
BioCentury | Apr 6, 2022
Discovery & Translation
A complete human genome; plus prime and base editing progress, COVID boosters
BioCentury’s roundup of translational news
BioCentury | Apr 1, 2022
Distillery Therapeutics
Inhibition of ATP1A2 for tauopathies including Alzheimer’s
BioCentury | Mar 11, 2022
Management Tracks
Sandrock joins board at Atalanta
Plus Imbria staffs C-suite and updates from Berkeley Lights, Akouos and more
Items per page:
1 - 10 of 91